Clinical Trial Update: Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication [EARLY_Phase 1]

View source ↗

Summary

An early-phase HIV eradication trial combining cytoreductive chemotherapy with a CCR5 coreceptor antagonist was terminated before completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: HIV-1 Infection | EARLY_Phase 1 | Status: TERMINATED